Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment.

Trial Profile

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2010

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SONAR
  • Sponsors Bayer
  • Most Recent Events

    • 21 Apr 2010 Planned number of patients changed from 2000 to 3114 as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Additional location (Romania) identified as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Planned number of patients changed from 2000 to 3114 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top